Chairman of the Board
Nils Siegbahn PhD, MBA, has vast experience from executive functions in pharma and medtech industry, such as KabiPharmacia Group, Perstorp AB, Atos Medical AB, Pernovo AB, Alligator Bioscience AB and Niconovum AB. He is currently engaged as board member in Sparbankstiftelsen I Syd Riskkapitalstiftelse and Celltrix AB, and previously as chairman of the board in Glycorex Transplantaion AB, Prosthetic Foot Co.
Gregory Batcheller has a strong background in emerging life science and pharmaceutical company development. He holds a JD from University of Toronto and a LLM from Lund University, Sweden. Greg is an accomplished dealmaker and has successfully negotiated many international licensing and M&A deals in Europe, the U.S., and China. Current assignments are Chairman of the Board of Xintela AB, Saga Diagnostics AB, Monocl AB, Immune Biotech Medical Sweden AB and CarryGenes Therapeutics AB.
Board member, alternate
Lars Hedbys contributes with over 30 years international experience from the life science industry, with more than 25 years in leading roles. He has a track record of leading listed companies, large operational organizations, organizations in change and growing life science companies to an IPO. He has led companies in various fields of the industry including pharmaceutical development, ATMP development, medical device development and marketing, contract research organisations as well as leading private medical clinics. His curriculum also includes a number of board membership roles.